Clinical Trials · NCT02449603
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Xijing Hospital
- Enrollment
- 150
- Start date
- Nov 2015
- Locations
- 1 site, China
- Primary endpoint
- Change of mean amplitude of glycemic excursions